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ALI DJALILIAN, MD, EDITORCorneal Bioﬁlms: From Planktonic to Microcolony
Formation in an Experimental Keratitis Infection
with Pseudomonas AeruginosaPADMANABHAN SARASWATHI, PHD, 1 AND ROGER W. BEUERMAN, PHD1,2,3ABSTRACT Purpose: Microbial bioﬁlms commonly
comprise part of the infectious scenario, complicating the
therapeutic approach. The purpose of this study was to
determine in a mouse model of corneal infection if mature
bioﬁlms formed and to visualize the stages of bioﬁlm for-
mation. Methods: A bacterial keratitis model was established
using Pseudomonas aeruginosa ATCC 9027 (1  108 CFU/ml)
to infect the cornea of C57BL/6 black mouse. Eyes were
examined post-infection (PI) on days 1, 2, 3, 5, and 7, and
imaged by slit lamp microscopy, and light, confocal, and
electron microscopy to identify the stages of bioﬁlm for-
mation and the time of appearance. Results: On PI day 1,
Gram staining showed rod-shaped bacteria adherent on the
corneal surface. On PI days 2 and 3, bacteria were seen
within webs of extracellular polymeric substance (EPS) and
glycocalyx secretion, imaged by confocal microscopy.
Scanning electron microscopy demonstrated microcolonies
of active infectious cells bound with thick ﬁbrous material.
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THE OCULAR SURFACE / OCTOBER 2015, VOformation of classical bioﬁlm architecture with P. aeruginosa
densely packed within the extracellular polymeric sub-
stances on PI days 5 and 7. Conclusion: Direct visual evi-
dence showed that bioﬁlms routinely developed on the
biotic surface of the mouse cornea. The mouse model can be
used to develop new approaches to deal therapeutically
with bioﬁlms in corneal infections.
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polymeric extracellular substance, Pseudomonas aeruginosaI. INTRODUCTIONB acterial and fungal infections of the ocular surfaceare common worldwide, particularly in SoutheastAsia, and can damage the structure of the cornea,
leading to visual disability or blindness.1-3 Recent microbio-
logical studies have emphasized that most pathogens prefer
to live in specialized communities called bioﬁlms rather than
as isolated organisms, the so-called planktonic state.4-6
Consequently, the role of bioﬁlms in infection management
has begun to receive more attention. Bacteria as individual
organisms are directly susceptible to environmental condi-
tions, including the presence of antibiotics; however, bio-
ﬁlms are associated with antibiotic resistance.7-9
Costerton and co-workers10,11 deﬁned a bioﬁlm as “a
structural community of bacterial cells enclosed in a self-
promoted matrix and adherent to an inert or living surface.”
The dynamic process of bioﬁlm formation is initiated by
adherence on a surface (abiotic or biotic) followed by prolif-
eration and attachment within a secreted matrix, which
enhances the modiﬁed phenotypes to form resistant infec-
tions.12-15 The secreted matrix referred to as extracellular
polymeric substances (EPS) protects the microbial commu-
nity, and antibiotic resistance of up to 1000 times has been
reported.4,5,16 Thus, it is currently thought that while most in-
fections will have a bioﬁlm phase, chronic infections may be
more prone to developing mature bioﬁlms, which may ac-
count for a lack of response to antibiotics.11,17 Development
of bioﬁlms on inert surfaces under laboratory conditions
have been well studied. Bioﬁlms on mucosal surfaces have
been documented in tonsillitis,18 rhinosinusitis,19 cysticL. 13 NO. 4 / www.theocularsurface.com 331
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CORNEAL BIOFILMS AND PSEUDOMONAS AERUGINOSA / Saraswathi and Beuermanﬁbrosis,20 and otitis media.21 Although bioﬁlms in the eye
have been discussed,22 there is no evidence that corneal infec-
tions develop mature bioﬁlms, which are the most likely to
contribute to treatment resistance.
Corneal infections are common complications of both
daily and extended wear contact lens wear, accounting for
12-66% of all microbial keratitis in Europe and the US.22-30
P. aeruginosa, an ubiquitous bioﬁlm producer, is often associ-
ated with contact lens wear, with a somewhat greater inci-
dence of infection in tropical climates.31-33 Bacterial
adhesion, an initial step in bioﬁlm formation, may be inﬂu-
enced by surface hydrophobicity,34 and subsequently forma-
tion of a sessile bioﬁlm anchors the bacteria to the surface of
the lenses. A worldwide outbreak of fungal keratitis due to
Fusarium solani infection was linked with a contaminated
multipurpose contact lens disinfecting solution.35 Although
bioﬁlms were not investigated at that time as a possible cause,
shortly thereafter, Imamura et al showed that Fusarium
readily forms bioﬁlms on contact lenses.36 Bioﬁlms have
also been associated with contact lens cases, and it was found
that 82/101 cases were contaminated; in 78 of those 82, the
primary contaminant was bacteria.37
Gram-positive cocci are also common corneal pathogens
reported in non-contact lens-related keratitis38-41 and
conjunctivitis.42 Infective crystalline keratopathy, an indo-
lent corneal infection may be caused by the accumulation
of bacterial EPS and is often due to Streptococcus viridans,
as well as Staphylococcus, Enterococcus or Candida.43-46
Medical treatments of infective crystalline keratopathy can
be difﬁcult due to the presence of a bioﬁlm, and laser ther-
apy in addition to antibiotics has been used to disrupt the
bioﬁlm.47 Endopthalmitis, a potentially blinding intraocular
infection, is a rare complication of cataract surgery48 in
which Staphyloccocus aureus and Staphyloccocus epidermidis
bioﬁlms have been identiﬁed.49-51 Additionally, materials
like sutures, scleral buckles, glaucoma tubes, stents, corneal
transplants, and other ocular prostheses are solid, abiotic
substrates that may contribute to the risk of an infection
complicated by bioﬁlm formation transferring into a biotic
bioﬁlm.52,53332 THE OCULAR SURFACE / OCTOBER 2015Antimicrobial treatments for bioﬁlm infections could
be problematic if based on the Minimum Inhibitory Con-
centration (MIC) breakpoints.54 The MIC of an antibiotic
is based on the Clinical Laboratory Standards Institute
(CLSI) microbiology testing method using planktonic
bacteria in the microbiology laboratory, which may be
inadequate for killing organisms embedded in bioﬁlms.
This has prompted the use of a new term called the Min-
imum Bioﬁlm Eradication Concentration (MBEC), as
higher concentrations of antibiotics could be necessary to
penetrate the bioﬁlm EPS matrix and kill the genetically
diverse population existing in the bioﬁlm community.55
Bioﬁlm treatment should involve 1) exploration of high
potency specialized drugs, 2) examination of drug delivery
mechanisms, and 3) determination of bioﬁlm vulnerabil-
ities. Developing a corneal model of bioﬁlms as presented
here may be particularly relevant, as there is opportunity to
correlate stage of bioﬁlm formation and antibiotic efﬁcacy
optimized for therapeutic outcomes and host immune
responses.
Structurally, a bioﬁlm consists of bacteria compacted by
a matrix of polymeric substances, built up over a substrate,
resulting in a three-dimensional biomass.56 Imaging
methods, including electron microscopy, are needed to visu-
alize the bioﬁlm architecture.57 Real time imaging of live
bioﬁlm structures with horizontal and vertical sectioning
of hydrated bioﬁlms by optical methods is feasible using
Confocal Laser Scanning Microscopy (CLSM).58 The pur-
pose of the present study was to utilize different imaging
methods to visualize the development of mature bacterial
bioﬁlms in an experimental infection of the mouse cornea
with an ATCC strain of P. aeruginosa. It was found that bio-
ﬁlms routinely develop in a standard model of infection in
the mouse, and the imaging results showed that all stages
of bioﬁlm development existed in experimental corneal in-
fections with Pseudomonas. The corneal bioﬁlm model is
particularly useful, as the infection can be easily followed
and observed.II. MATERIALS AND METHODS
A. Animal Use
Wild type C57BL/6 mice (7-8 weeks old) purchased
from the National University of Singapore (NUS) were
used in this study. Handling and care of all animals were
performed according to the guidelines adopted by Sing-
Health Institutional Animal Care and Use Committee
(IACUC), and the study was carried out in accordance
with the Association for Research in Vision and Ophthal-
mology (ARVO) guidelines for animal experimentation.
B. Bacteria
P. aeruginosa ATCC 9027 strain was grown overnight in
Tryptic Soy Agar (TSA) Plates at 35 C. Colonies were
picked up and suspended in sterile saline at a concentration
of 1  108 CFU/mL for use in this study., VOL. 13 NO. 4 / www.theocularsurface.com
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Initially, all eyes of the mice were examined by slit lamp
to ensure that there were no corneal abnormalities, such as
vascularization or other defects. Mice were anesthetized by
an intraperitoneal injection of xylazine (10 mg/kg, Troy
Laboratories, Smithﬁeld, Australia) and ketamine (80 mg/
kg, Ketamine, Parnell Laboratories, Australia). With the
aid of a dissecting microscope (Zeiss, Stemi-2000 C), four
superﬁcial abrasions of 1-2 mm in length were made on
the corneal epithelium, using a sterile miniblade (BD-Beaver
no-376400), and immediately a 5-ml aliquot of P. aeruginosa
suspension was applied topically on the cornea. The eyes
were examined daily by slit lamp and sacriﬁced at PI days
1, 2, 3, 5, and 7 for imaging. Separate groups of mice
were used for slit lamp microscopy, light microscopy,
CLSM, SEM and TEM analysis (n ¼ 6 mice/group).
D. Slit Lamp Microscopy
The corneal infection was followed by slit lamp micro-
scopy over the course of the study. The corneal surface
was photographed under normal light and after ﬂuorescein
instillation (2%) by slit lamp (NS-2D, Righton, Tokyo,
Japan).
E. Light Microscopy
At each time point, globes were enucleated and ﬁxed in
Hartmann’s ﬁxative (Sigma) and stored at 4C. Eyes were
washed and processed in a Sakura Tissue-Tek R VIPTM 5
and embedded (Tissue-Tek R TEC TM Parafﬁn Embedding
Centre). Sections were cut at 5 mm using a Leica RM2255
microtome, then dried, deparafﬁnized and hydrated using
a graded series of alcohols, and stained with Brown-Hopps
Gram stain.59 Selected areas of the stained sections were
imaged (Axioplan 2; Carl Zeissmeditec GmbH, Oberkochen,
Germany).
F. Confocal Laser Scanning Microscopy
CLSM was used with dual staining to assess the presence
of bacterial bioﬁlms on the corneal surface. Confocal imag-
ing using ﬂuorescent material is a useful tool to study bio-
ﬁlm on its cellular biochemical identiﬁcation of the bioﬁlm
glycocalyx, and it does not require ﬁxation.60 At each time
point, corneas were dissected from the globe, washed with
phosphate buffered saline (PBS) and stained with propi-
dium iodide (Live/Dead BacLight TM bacterial viability
kiteInvitrogen, Molecular Probes, Eugene, OR) for 15 mi-
nutes at room temperature. After being washed in PBS,
the corneas were stained with 50 mg/mL of ﬂuorescein
isothiocyanate-conjugated concanavalin A (FITC-con A,
Sigma-Aldrich Corp, St. Louis, MO, USA) for 15 minutes
at room temperature to stain the extracellular secretions.
After staining, corneas were washed three times with PBS
followed by sterile deionized water, and mounted on slides
for imaging. Propidium Iodide was imaged at 520 nm, the
emission was monitored at 620 nm, and FITC-con A was
excited and monitored at 495 nm and 525 nm, respectively.
Images were collected using a Carl Zeiss LSM710 confocalTHE OCULAR SURFACE / OCTOBER 2015, VOmicroscope and Zen software was used for image
processing.
G. Scanning Electron Microscopy
Bacteria on the corneal surface were imaged with SEM at
1, 2, 3, 5, and 7 days PI. The globes were enucleated, washed
in PBS and preﬁxed in 1 ml of a mixed aldehyde ﬁxative (2%
glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium
cacodylate buffer, pH 7.2) for 24 hours. Then the samples
were washed in sodium cacodylate buffer (Electron Micro-
scopy Sciences, Washington, USA) and subsequently
post-ﬁxed in 1% osmium tetroxide (Electron Microscopy
Sciences, Washington, USA). After post-ﬁxation, samples
were washed in sodium cacodylate buffer and dehydrated,
using an ascending series of ethanol solutions. Following
dehydration, the samples were critical-point-dried, attached
to carbon stubs, and sputter-coated with 10 nm of gold. All
samples were seen and photographed on a FESEM at an
accelerating voltage of 3 kV at the Carl Zeiss Microscopic
facility at the National University of Singapore.
H. Transmission Electron Microscopy
TEM was utilized to view the adherence, invasion, and
bioﬁlm formation on the cornea. On PI days 1, 2, 3, 5, and
7, corneas were dissected from the globe, washed in PBS,
and preﬁxed in 1 ml of a mixed aldehyde ﬁxative (2% glutar-
aldehyde and 2% paraformaldehyde in 0.1 M sodium cacody-
late buffer, pH 7.2) for 24 hours. Samples were subsequently
washed in sodium cacodylate buffer (Electron Microscopy
Sciences, Washington, USA) and subsequently post-ﬁxed in
1% osmium tetroxide (Electron Microscopy Sciences, Wash-
ington, USA). For post-ﬁxation, samples were again washed
in sodium cacodylate buffer and dehydrated, using an
ascending series of ethanol solutions and embedded in aral-
dite (Electron Microscopy Sciences, Washington, USA).
Ultrathin sections (90 nm) were cut from blocks with a
Reichert-Jung Ultracut E Ultramicrotome (C.Reichert
Optiche Werks AG, Vienna Austria). All ultrathin sections
were collected on copper grids and doubled-stained with ura-
nyl acetate and lead citrate for 20 minutes, dried, and viewed
under a TEM (JEOL- JEM1010, NUS Electron Microscopy
Facility, National University of Singapore, Singapore) at
100 kV and the areas of interest were photographed. Other
than brightness and contrast, no other image processing
adjustments were made to the images.III. RESULTS
The normal structure of the mouse cornea was, of course,
dramatically affected by the progress of the experimental bac-
terial infection. In this study, we were primarily interested in
the appearance of immune cells, especially neutrophils, and
also in determining if the bacteria remained as in a plank-
tonic stage or if the classic signs of bioﬁlm formation were
discernible. Although the steps leading to bioﬁlm formation
are described below in detail, it may be helpful to refer to
an overall chart of the events below in Table 1.L. 13 NO. 4 / www.theocularsurface.com 333
Table 1. Summary of Bioﬁlm Development
Time of infection
Slit-lamp imaging CLSM imaging
Light microscopy
imaging Electron microscopy imaging Bacterial
architecture
Corneal opacity Epithelial defect
Glycocalyx
staining Gram staining SEM TEM
Before Infection No No Negative No bacteria No bacteria No bacteria No bacteria
PI-Day 1 Yes 6/6 Yes 6/6 Negative 6/6 Pink stained rod
shaped bacteria
Typical rod shaped
bacteria with clear
boundaries and
smooth
morphology
Planktonic bacteria Planktonic bacteria
PI-Day 2 Yes 6/6 Yes 6/6 Positive 6/6 Bacteria organized
into clusters
Small micro col-
onies with ﬁbrous,
hard extracellular
substances
Bacteria settled into
basal, middle and
top layered
organisation
Attachment and
colony formation
PI-Day 3 Yes 6/6 Yes 6/6 Highly positive 6/6 Bacteria formed a
ﬁlmy sheet of hazy
cover
Bacteria inter-
mingled with dense
ﬁbrous substances
and organized as
mushroom shaped
bodies and tower
like structures
Thick rigid layer of
bioﬁlm in which
bacteria were got-
ten embedded in
extracellular
substances
Bioﬁlm bacteria
PI-Day 5 Yes 6/6 Yes
Even 4/6
Uneven 2/6
Highly positive 6/6 Bacteria formed a
thick layer on the
surface
Consolidated bio-
ﬁlm bacteria
evident with
increased secretion
Compact mass of
bioﬁlm in which
bacteria were
entrenched inside
the extracellular
substances
Bioﬁlm bacteria
PI-Day 7 Yes 6/6 Yes
Even 4/6
Uneven 2/6
Highly Positive 6/6 Bacteria formed a
thick layer on the
surface
Bioﬁlm bacteria
occupied large area
but with a slightly
compressed form
Strong attachment
of bioﬁlm and the
bacteria were static
inside the secreted
substances
Bioﬁlm bacteria
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CORNEAL BIOFILMS AND PSEUDOMONAS AERUGINOSA / Saraswathi and BeuermanThe mouse cornea prior to infection was structurally
intact, and ﬂuorescent images did not reveal staining
(Figure 1-A1 and A2). CLSM images were negative for
FITC-con A and propidium iodide staining revealed cornealFigure 1. Structural status of the cornea before infection. The corneas of t
appeared normal. A1. Image taken in normal light and (A2) after instillation o
of the normal corneal epithelial cells (X63) and FITC-con A was not detected
(X63); well-deﬁned epithelial cell organization (Epi) and compact stroma (St)
agonal outer epithelial cell (Epi) layer with tightly adherent lateral cell border
image of corneal epithelium; microvilli (Mv) and cell features such as mitoch
THE OCULAR SURFACE / OCTOBER 2015, VOepithelial cells (Figure 1-B). Imaging the glycocalyx provided
a means of showing the EPS as a bioﬁlm marker. Histology
with Gram staining displayed well-deﬁned corneal layers
with normally arranged epithelial cells and compact stromahe mice used in these studies were initially examined by slit lamp and
f ﬂuorescein. B. CLSM imaging, propidium iodide produced little staining
. C. Cellular organization of the normal cornea following Gram staining
were present. D1. SEM image of corneal surface cells showed the hex-
s. D2. Higher magniﬁcation SEM image showing microvilli (Mv). E1. TEM
ondria (Mc) and desmosomes were seen at high magniﬁcation (E2).
L. 13 NO. 4 / www.theocularsurface.com 335
Figure 2. Post infection day 1. A1. Slit lamp images of mice cornea on PI day 1 with corneal opacity and (A2) epithelial defect and ﬂuorescein
staining. B. CLSM image (X40) showed limited staining by FITC-con A, and corneal epithelium faint red in color. C. Gram staining revealed P. aeruginosa
on the surface of the cornea with remnants of the epithelium (Epi). Stroma (St) and Neutrophils (N) (Black arrow indicates bacteria). D1. SEM image of
CORNEAL BIOFILMS AND PSEUDOMONAS AERUGINOSA / Saraswathi and Beuerman
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=CORNEAL BIOFILMS AND PSEUDOMONAS AERUGINOSA / Saraswathi and Beuermanwith keratocytes, but without neutrophils (Figure 1-C). SEM
showed a smooth layer of hexagonal epithelial cells with well-
deﬁned lateral borders (Figure 1-D1) and microvilli, visible at
high magniﬁcation (Figure 1-D2). TEM revealed the normal
corneal epithelial organization (Figure 1-E1), and in
Figure 1-E2 the epithelial cells and microvilli were seen un-
damaged in higher magniﬁcation. The overall appearance
was similar to what has been previously described for the hu-
man cornea.61,62 At PI day 1, corneal structural changes re-
ﬂected the rapid pace of the infection, the epithelium was
damaged, and an opacity forming (Figure 2-A1 and A2)
with very little FITC-con A staining as in Figure 2-B. Gram
staining showed P. aeruginosa, as typical rod-shaped appear-
ance, pink in color (Figure 2-C). Histologically, the corneal
surface was occupied with remnants of epithelium and
numerous neutrophils migrated into the stroma (Fig 2-C).
SEM images showed adherent bacteria at sites over the surface
of the cornea (Figure 2-D1). A ﬁne network extended over the
bacteria was likely the release of Neutrophil Extracellular
Traps (NETs), which were visible at high magniﬁcation
(Figure 2-D2). TEM corroborated epithelial damage and
P. aeruginosa had already invaded into the stroma, with
some bacteria engulfed by neutrophils (Fig 2-E).
Thus, on PI day 1, P. aeruginosa infection was accompa-
nied by corneal damage with the rod-shaped bacteria seen
scattered discretely in small groups, along with neutrophil
activity. On PI day 2, increasing opacity and epithelial dam-
age were seen along with positive glycocalyx staining.
Figure 3-B shows the corneal epithelium with faint red
staining of propidium iodide, while neutrophils were distin-
guished by a dark red color with a few positioned above the
green-stained areas (Figure 3-B). Light microscopy revealed
clusters of darkly staining bacteria adhering to the stroma
(Figure 3-C). By SEM, small colonies of bacteria were
seen (Figure 3-D1) at higher magniﬁcation; the bacteria
were trapped within a more dense ﬁbrous material
(Figure 3-D2). These microcolonies did not cover large
areas, but were localized as patches with active cells
(Figure 3-D2). At PI day 2, bacteria became arranged in a
unique layered architecture, conﬁrming the formation of a
structured bioﬁlm (Figure 3-E1). Bacteria in the basal layer
were loosely ﬁxed in the secreted matrix, but in the middle
layer, the bacteria appeared tightly packed with an electron-
dense ﬁbrous substance bound closely to the organisms.
However, bacteria in the top layer appeared more mobile,
as in Figure 3-E2.
Increased corneal opacity, hypopyon, and vasculariza-
tion were characterized on PI day 3 (Figure 4-A1). An
epithelial defect (Figure 4-A2) with an uneven distribution
of ﬂuorescein staining was seen in some miceinfected mice cornea; bacteria are scattered on the corneal surface and orga
P. aeruginosa on the corneal stroma (St). Network ﬁbrils were seen over th
extracellular traps from the neutrophils. E. TEM image of infected mice cor
stroma (St). Some bacteria were observed to be engulfed by neutrophils (bl
THE OCULAR SURFACE / OCTOBER 2015, VO(Table 1).63,69 FITC-con A staining revealed an amorphous
material within the ulcer, occupying much of the corneal
surface (Figure 4-B). Distinct bacteria were not clear, but
vaguely visible embedded within the ﬁbrous matter. Light
microscopy imaging revealed bacterial clusters and
numerous neutrophils in the stroma (Figure 4-C). SEM
showed a mature bioﬁlm on the severely damaged corneal
surface, including the diagnostic mushroom-shaped bodies
and tower-like structures in which the bacteria are ﬁrmly
attached within the matrix (Figure 4-D1). Free bacteria
were seen in less involved areas of the cornea and below
the bioﬁlm clusters (Figures 4-D2 and D3). Neutrophils
were noted on the surface of the bioﬁlm, while bacteria
were deep-packed within the EPS. At this stage, the ultra-
structure of the bioﬁlm diverged from the previous stages.
Bacterial cells were arranged compactly as a rigid layer
with some neutrophils (Figure 4-E1). Thus, the established
bioﬁlm with the secreted EPS incorporating the bacteria
were seen, as in images in Figure 4-E2. On PI days 5-7,
the corneal opacity with hypopyon and vascularization
were largely unchanged (Figure 5-A1 and 6-A1) with a
marked ﬂuorescein uptake (Figures 5-A2 and 6-A2).
FITC-con A staining was the same as the earlier stages of
the bioﬁlm (Figures 5-B and 6-B). During these later stages
of infection, neutrophils were observed in the anterior
stroma. Individual bacteria were not clearly visible and
were probably masked by the EPS, which could be seen by
light microscopy (Figures 5-C and 6-C). SEM images
showed P. aeruginosa and neutrophils on the surface of
the bioﬁlm, as in the earlier bioﬁlm stages without release
of NETs (Figures 5-D1 and 5-D2). Some bacterial constella-
tions were seen occupying large areas of the cornea, and the
bioﬁlm assembly appeared slightly compressed on PI day 7
(Figures 6-D1 and D2); however, the buildup of the bioﬁlm
body was alike from PI days 5 to 7. TEM also indicated a
strong attachment of the P. aeruginosa bioﬁlm onto the
mouse cornea (Figures 5-E1 and 6-E1), and the bacterial
cells appeared immobile inside the secreted material
(Figures 5-E2 and 6-E2). Overall, the areal extent of the bio-
ﬁlm enlarged with bacteria more deeply embedded within
the secreted matrix. Thus, the architectural shift of plank-
tonic bacteria to microcolonies proceeded fairly rapidly in
all corneas and then evolved into a mature bioﬁlm covering
larger areas of the cornea.
IV. DISCUSSION
Research on corneal infections has detailed many aspects
of an infection: microbial adhesion, corneal pathogenicity,
role of immune cells, and mechanisms of innate and
adaptive immunity on ocular microbiology.62-69 Bioﬁlmnized in small groups. (Black arrow). D2. Magniﬁed view of a cluster of
e surface of bacterial clusters (White arrow), which were probably the
nea. P. aeruginosa were seen within the damaged epithelium (Epi) and
ack arrow).
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Figure 3. Post-infection day 2. A1. Corneal opacity. A2. Intense ﬂuorescein staining across the cornea. B. Appearance of strong FITC-con A (green)
staining by CLSM (X40) revealed the presence of glycocalyx. Propidium iodide left the corneal epithelium with a faint red color while neutrophils were
stained a darker red and were distributed around and above the glycocalyx. C. Small clusters of P. aeruginosa (colonies) attached to the stroma were
seen by Gram staining. D1. Black arrows indicate attached colonies of P. aeruginosa with a few detached cells. D2. SEM shows bacteria in microcolonies
(black arrow) attached on the corneal surface. Magniﬁed view of a microcolony; bacteria were seen in the matrix (black arrow) and dividing cells were
present inside the colony (white arrow). E1 and E2. TEM images showing an organized bioﬁlms. Densely packed P. aeruginosa accumulated on the
corneal surface. E1. At high magniﬁcation the bacteria appeared in layers. E2. Bacteria within the electron-dense matrix formed the basal (b) and
middle layers (m). Bacteria in the top layer were seen to be less attached and free to move to a planktonic mode (t).
CORNEAL BIOFILMS AND PSEUDOMONAS AERUGINOSA / Saraswathi and Beuermaninfections of the eye have been discussed in a recent re-
view.22 The development of corneal bioﬁlm has not been
observed; this is important, as antibiotic resistance is found338 THE OCULAR SURFACE / OCTOBER 2015more when the EPS compacts the bacteria. The present
study has provided structural evidence for the classical
stages of bioﬁlm formation in an experimental infection in, VOL. 13 NO. 4 / www.theocularsurface.com
Figure 4. Post-infection day 3. A1. On PI day 4, hypopyon and vascularization were observed. A2. Pan corneal ﬂuorescein staining. B. CLSM showed
more intense staining, indicating an increase in the bioﬁlm glycocalyx (X40). C. Clusters of bacteria appeared on the corneal surface, and neutrophils
were seen in the anterior stroma. D1. SEM revealed a mature bioﬁlm with mushroom-shaped structures (thick black arrow) along with extensive
epithelial loss and damage. D2 and D3. The area marked by an + are seen in higher magniﬁcation. In D2, a tower-like structure consisted of a dense
matrix and embedded bacteria. The portion of the bioﬁlm in D3 showed bacteria emerging from the bioﬁlm. E1. TEM microphotograph of a compact
layer of bacteria with neutrophils, about 60 microns thick. E2. As on the previous day, E2 shows that bacteria can emerge from the compact matrix.
CORNEAL BIOFILMS AND PSEUDOMONAS AERUGINOSA / Saraswathi and Beuermanthe mouse cornea. This model can be used to determine how
bioﬁlms affect therapeutic outcomes.
The bioﬁlm required more than 24 hours to form in
the mouse cornea and was accompanied by a slight opacityTHE OCULAR SURFACE / OCTOBER 2015, VOat PI day 1 without FITC-con A staining, indicating that
the bacteria had not yet begun to form an EPS. Bacteria
were planktonic in the early stages of the infection, as evi-
denced by the presence of rod-shaped P. aeruginosa asL. 13 NO. 4 / www.theocularsurface.com 339
Figure 5. Post-infection day 5. On PI day 5, slit lamp images A1 and A2 reveal the continued severity of the infection as a continuation of PI Day 3,
characterized by hypopyon, ﬂuorescein staining, and vascularization. B. FITC-con A staining using CLSM (X40). C. Gram staining revealed disorganized
layers of epithelial cells immersed in a matrix with background staining along with neutrophils. SEM image in D1 demonstrated dense mats of
P. aeruginosa bioﬁlm attached to the corneal surface. +- Area magniﬁed further illustrates masses of bacteria embedded in a dense matrix (D2). TEM
images (E1 and E2) conﬁrm P. aeruginosa bioﬁlm with similar morphology and organized as in PI day 3.
CORNEAL BIOFILMS AND PSEUDOMONAS AERUGINOSA / Saraswathi and Beuermandiscrete single organisms. Additionally, SEM images
conﬁrmed that P. aeruginosa were not embedded within
electron-dense substances, but were shown to be trapped
by NETs. Furthermore, phagocytosis by neutrophils, as
observed in TEM images, indicated an early immune340 THE OCULAR SURFACE / OCTOBER 2015defense. The strain of Pseudomonas ATCC 9027 has
been found to be a moderate bioﬁlm producer, and as
used in our laboratory for several years, shows consistent
sensitivity to most antimicrobials at low MIC levels.70-72
ATCC 9027 does have some ability to invade epithelial, VOL. 13 NO. 4 / www.theocularsurface.com
Figure 6. Post-infection day 7. On PI day 7, slit lamp iamges A1 and A2 with ﬂuorescein show little change from PI day 5. An increase in secreted
matrix as well as release of material from the cornea and neutrophils changed the microscopic views, as observed in Figure 5. B. CLSM image
continued to reveal large glycocalyx covered bioﬁlm, but was somewhat less intense than at PI Day 5 (X40). C. Gram staining appears as an exudate
overlying the corneal surface containing epithelial cells and neutrophils. SEM (D1) and TEM (E1) photographs demonstrate P. aruginosa bioﬁlm
outsized the corneal surface, + - area magniﬁed further as in D2, presence of ghosts of bacteria in the matrix (E2).
CORNEAL BIOFILMS AND PSEUDOMONAS AERUGINOSA / Saraswathi and Beuermancells, which would be in counter-distinction to their ability
to form bioﬁlms.73
The obvious corneal opacity on PI day 2 and FITC-con
A staining were evident and detected by CLSM imaging,THE OCULAR SURFACE / OCTOBER 2015, VOcorroborating other studies.74 Positive staining for FITC-
con A revealed the secretion of a bacterial glycocalyx, the
EPS, which promotes adherence to nearby bacilli as well
as to the corneal surface, producing the sessile bioﬁlm.7,75L. 13 NO. 4 / www.theocularsurface.com 341
CORNEAL BIOFILMS AND PSEUDOMONAS AERUGINOSA / Saraswathi and BeuermanGram staining showed distinct clusters of attached bacteria
on PI day 1. Similarly, the presence of densely packed
masses of bacterial bioﬁlms in nasal polyps of patients was
conﬁrmed using Gram staining.76
Small microcolonies of P. aeruginosa seen by SEM were
organized as a bioﬁlm with bacterial cells embedded inside
the ﬁbrous material. The arrangement of microcolonies as
patches could be clearly distinguished from the ridges and
folds of the damaged corneal surface. Bacterial cells
appeared healthy and the dividing cells within the microcol-
ony indicated viability. TEM further deﬁned bioﬁlm archi-
tecture of P. aeruginosa with the bacteria spatially
arranged as basal, middle, and top layer. Thus, by PI day
2, considerable evidence for the initiation of bioﬁlm forma-
tion on the mouse cornea was obtained.
At PI day 3, FITC-con A staining of ﬁbrous structures
and masses of bacteria denoted the EPS, glycocalyx, and
maturation of the bioﬁlm. Imaging bacterial cells as well
as the matrix on mucosal bioﬁlms was achieved by using
a dual staining technique in combination with CLSM.75,77,78
Confocal imaging was also used to demonstrate the
presence of bioﬁlms in patients with tonsillitis.18 FITC-
con A has a high afﬁnity for sugar residues, which specif-
ically bind to a-mannose (2-epimer of D-glucose) residues
of the polysaccharides and is considered as a marker for
detecting the bioﬁlm glycocalyx.74,75,77,78 Neutrophils
seen by light and electron microscopy around masses of
bacteria were notable. Patches of bacteria within
network-like organizations consisting of active cells were
imaged on the surface of the tonsillar epithelium by
SEM.18 In another study, Robert et al used SEM to detect
group A Streptococcus bioﬁlms on the epithelial crypts of
tonsillar tissues of pediatric patients.79 Planktonic bacteria
scattered underneath the mushroom-shaped bodies, indi-
cated possible detachment from the mature bioﬁlm. The
ultrastructure of the bioﬁlm differs from the preceding
stage as it was comprised of packed bacteria as a dense
rigid stratum.
On PI day 5, CLSM as well as light and electron micro-
scopy observations, revealed the continuous presence of the
mature bioﬁlm, which was apparently active even with the
host immune response. SEM images of pneumococcal bio-
ﬁlms on nasopharyngeal tissues and thick bacterial bioﬁlms
of nontypable Haemophilus inﬂuenzae encrusted on chin-
chilla middle-ear mucosa were similarly described.80
Another study of imaging with SEM and CLSM provided
evidence for bioﬁlm formation in an experimental model
of otitis media.81 In the later stages of infection, the bacte-
ria were not clearly visible and were probably masked by
the increased secretion of EPS. In this study, bioﬁlm forma-
tion persisted until PI day 7 with corneal perforation in a
few cases (2 mice were immediately sacriﬁced at that
point).
Our results using Gram staining were useful in differ-
entiating planktonic and bioﬁlm stages of P. aeruginosa in
the infected eye. Gram staining, a simple but older tech-
nique, is considered as a “gold standard’’ in clinical342 THE OCULAR SURFACE / OCTOBER 2015microbiology. Normal hematoxylin and eosin staining
have also been useful to detect and conﬁrm the existence
of bioﬁlms in patient samples.82 Recently, Fluorescence
in Situ Hybridization (FISH)83 has also been used; how-
ever, Gram staining seems to be a simpler technique,
particularly when corroborated by other methods. The im-
aging techniques applied here are particularly advanta-
geous in microbiology studies, especially the combination
of CLSM and SEM. CLSM also enables the quantiﬁcation
of 3-dimensional bioﬁlm structures in mucosal tissues.84
The bioﬁlm-forming ability of Staphylococcus aureus, a
major pathogen for bovine mastitis was also detected by gly-
cocalyx production.85 In damaged skin, CLSM was used to
detect glycocalyx of S. aureus bioﬁlms 4 hours after bacterial
inoculation.86 CLSM was used to detect bioﬁlms in skin le-
sions of bullous impetigo, atopic dermatitis, and Pemphigus
foliaceus,87 and upper airways in otolaryngology diseases.88
Thus, CLSM imaging has an important role in bioﬁlm
research, as it does not require dehydration of tissues and
provides better preservation of bioﬁlm structure.
Our SEM study substantiated bioﬁlm development from
P. aeruginosa on the infected eye with morphologically well-
distinguished stages of mature bioﬁlm formation. TEM im-
ages revealed that P. aeruginosa maintained its rod-shaped
morphology irrespective of planktonic stage or matrix
embedded bioﬁlm microcolonies. Chole et al observed
more complex bioﬁlm colonies with densely packed bacteria
of varying morphological appearance by TEM and the cells
were seen in a homogeneous amorphous matrix.89
In an ultrastructural study of endodontic bioﬁlm com-
munities, lytic bacteria were seen anchored in a collagenous
matrix with a variety of morphologies with signiﬁcant differ-
ences in precise spatial arrangements.90 However, the
corneal infections, as reported here, and subsequent bioﬁlm
formation are a site where all stages of bioﬁlm formation
have been easily imaged.
Limitations of the present study may be in the control
group; the cornea was imaged prior to infection, and sepa-
rate groups of mice were used for various imaging proce-
dures. The aim of the current study was to determine the
organizational details of P. aerguinosa in planktonic and
bioﬁlm modes in vivo. An experimental infection of the
mouse cornea is straight-forward and particularly useful
for bioﬁlm studies, as the corneal surface changes can be
correlated with in vivo observations. The current experi-
ments have used real-time imaging, documenting the devel-
oping bioﬁlms on the biotic surfaces of the cornea in the
absence of abiotic material.91 The results explained the exis-
tence of bioﬁlm formation in the eye in a standard infection
and may be useful to determine the impact of bioﬁlms on
therapeutic efforts and as one of the targeted domains of
the Human Microbiome Project launched by the National
Institutes of Health.92
V. CONCLUSION
This study provides strong direct evidence for the occur-
rence of bacterial bioﬁlm formation on the corneal surface, VOL. 13 NO. 4 / www.theocularsurface.com
CORNEAL BIOFILMS AND PSEUDOMONAS AERUGINOSA / Saraswathi and Beuermanof the mice in an experimentally induced P. aeruginosa kera-
titis infection. The results suggest that mature bioﬁlms are a
common component of keratitis and need to be considered
as a source of therapeutic difﬁculty when resistance to treat-
ment occurs.
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